+Compare
CRON
Stock ticker:
NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
1.32B

CRON Price Prediction, Cronos Group AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar

GET INTRADAY SIGNALS
CRON Trading results, last 6 months
AI Robots NameP/L
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EST Dec 02, 2022

CRON in upward trend: price rose above 50-day moving average on November 18, 2022

CRON moved above its 50-day moving average on November 18, 2022 date and that indicates a change from a downward trend to an upward trend. In 40 of 49 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 29, 2022. You may want to consider a long position or call options on CRON as a result. In of 111 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CRON just turned positive on November 18, 2022. Looking at past instances where CRON's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for CRON crossed bullishly above the 50-day moving average on November 22, 2022. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CRON advanced for three days, in of 232 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRON declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CRON broke above its upper Bollinger Band on December 01, 2022. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CRON’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.097) is normal, around the industry mean (5.923). P/E Ratio (0.000) is within average values for comparable stocks, (48.008). CRON's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.500). CRON has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.024). P/S Ratio (13.717) is also within normal values, averaging (115.015).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRON’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

AI
A.I.Advisor
published price charts
AI
A.I. Advisor
published Earnings

CRON is expected to report earnings to fall 49.90% to -5 cents per share on May 01

Cronos Group CRON Stock Earnings Reports
Q4'22
Est.
$-0.05
Q3'22
Missed
by $0.04
Q2'22
Beat
by $0.01
Q1'22
Missed
by $0.01
Q4'21
Missed
by $0.25
The last earnings report on November 07 showed earnings per share of -10 cents, missing the estimate of -5 cents. With 3.27M shares outstanding, the current market capitalization sits at 1.32B.
AI
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Elanco Animal Health (NYSE:ELAN), Intra-Cellular Therapies (NASDAQ:ITCI), Bausch Health Companies (NYSE:BHC), Tilray Brands (NASDAQ:TLRY), Canopy Growth Corp (NASDAQ:CGC), Avadel Pharmaceuticals plc (NASDAQ:AVDL), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 2.11B. The market cap for tickers in the group ranges from 246 to 81.18B. MKKGY holds the highest valuation in this group at 81.18B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was 2%. For the same Industry, the average monthly price growth was 6%, and the average quarterly price growth was -18%. TCNAF experienced the highest price growth at 124%, while KOAN experienced the biggest fall at -44%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was 115%. For the same stocks of the Industry, the average monthly volume growth was 105% and the average quarterly volume growth was -7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 72
Price Growth Rating: 66
SMR Rating: 57
Profit Risk Rating: 92
Seasonality Score: 24 (-100 ... +100)
AI
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
AI
A.I. Advisor
published General Information

General Information

pharmaceutical, medical marijuana, cannabis

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
111 Peter Street
Phone
+1 416 504-0004
Employees
628
Web
https://www.thecronosgroup.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSGAX12.310.07
+0.57%
Meridian Small Cap Growth A
MMQIX10.490.03
+0.29%
MassMutual Small Cap Val Eq I
MAGRX35.250.03
+0.09%
BlackRock Natural Resources Instl
JUSRX18.98N/A
N/A
JPMorgan US Equity R5
THGCX18.60-0.05
-0.27%
Thornburg International Equity C

CRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRON has been closely correlated with OGI. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRON jumps, then OGI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRON
1D Price
Change %
CRON100%
+6.13%
OGI - CRON
82%
Closely correlated
+8.18%
TLRY - CRON
81%
Closely correlated
+9.83%
CGC - CRON
77%
Closely correlated
+9.16%
ACB - CRON
71%
Closely correlated
+6.06%
SNDL - CRON
70%
Closely correlated
+8.68%
More